Roche’s Genentech Names Insider Bill Anderson New CEO

Xconomy San Francisco — 

The Genentech division of Roche said that Bill Anderson, who has been with the company for a decade, will replace Ian Clark as CEO. Anderson has been running North American commercial operations, the company said. He joined South San Francisco, CA-based Genentech in 2006 from Biogen, where he held a top spot in the neurology business. The changeover takes place January 1.